Cargando…

Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts

Toxicometabolomics, essentially applying metabolomics to toxicology of endogenous compounds such as drugs of abuse or new psychoactive substances (NPS), can be investigated by using different in vitro models and dedicated metabolomics techniques to enhance the number of relevant findings. The presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Manier, Sascha K., Wagmann, Lea, Flockerzi, Veit, Meyer, Markus R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303098/
https://www.ncbi.nlm.nih.gov/pubmed/32313995
http://dx.doi.org/10.1007/s00204-020-02742-1
_version_ 1783547976819408896
author Manier, Sascha K.
Wagmann, Lea
Flockerzi, Veit
Meyer, Markus R.
author_facet Manier, Sascha K.
Wagmann, Lea
Flockerzi, Veit
Meyer, Markus R.
author_sort Manier, Sascha K.
collection PubMed
description Toxicometabolomics, essentially applying metabolomics to toxicology of endogenous compounds such as drugs of abuse or new psychoactive substances (NPS), can be investigated by using different in vitro models and dedicated metabolomics techniques to enhance the number of relevant findings. The present study aimed to study the toxicometabolomics of the two NPS α-pyrrolidinobutiophenone (1-phenyl-2-(pyrrolidin-1-yl)butan-1-one, α-PBP) and α-pyrrolidinoheptaphenone (1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one, α-PEP, PV8) in HepaRG cell line incubates. Evaluation was performed using reversed-phase and normal-phase liquid chromatography coupled with high-resolution mass spectrometry in positive and negative ionization mode, respectively, to analyze cells and cell media. Statistical evaluation was performed using one-way ANOVA, principal component discriminant function analysis, as well as hierarchical clustering. In general, the analysis of cells did not mainly reveal any features, but the parent compounds of the drugs of abuse. For α-PBP an increase in N-methylnicotinamide was found, which may indicate hepatotoxic potential of the substance. After analysis of cell media, significant features led to the identification of several metabolites of both compounds. Amino acid adducts with glycine and alanine were found, and these have not been described in any study before and are likely to appear in vivo. Additionally, significant changes in the metabolism of cholesterol were revealed after incubation with α-PEP. In summary, the application of metabolomics techniques after HepaRG cells exposure to NPS did not lead to an increased number of identified drug metabolites compared to previously published studies, but gave a wider perspective on the physiological effect of the investigated compounds on human liver cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00204-020-02742-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7303098
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-73030982020-06-22 Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts Manier, Sascha K. Wagmann, Lea Flockerzi, Veit Meyer, Markus R. Arch Toxicol Toxicogenomics and Omics Technologies Toxicometabolomics, essentially applying metabolomics to toxicology of endogenous compounds such as drugs of abuse or new psychoactive substances (NPS), can be investigated by using different in vitro models and dedicated metabolomics techniques to enhance the number of relevant findings. The present study aimed to study the toxicometabolomics of the two NPS α-pyrrolidinobutiophenone (1-phenyl-2-(pyrrolidin-1-yl)butan-1-one, α-PBP) and α-pyrrolidinoheptaphenone (1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one, α-PEP, PV8) in HepaRG cell line incubates. Evaluation was performed using reversed-phase and normal-phase liquid chromatography coupled with high-resolution mass spectrometry in positive and negative ionization mode, respectively, to analyze cells and cell media. Statistical evaluation was performed using one-way ANOVA, principal component discriminant function analysis, as well as hierarchical clustering. In general, the analysis of cells did not mainly reveal any features, but the parent compounds of the drugs of abuse. For α-PBP an increase in N-methylnicotinamide was found, which may indicate hepatotoxic potential of the substance. After analysis of cell media, significant features led to the identification of several metabolites of both compounds. Amino acid adducts with glycine and alanine were found, and these have not been described in any study before and are likely to appear in vivo. Additionally, significant changes in the metabolism of cholesterol were revealed after incubation with α-PEP. In summary, the application of metabolomics techniques after HepaRG cells exposure to NPS did not lead to an increased number of identified drug metabolites compared to previously published studies, but gave a wider perspective on the physiological effect of the investigated compounds on human liver cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00204-020-02742-1) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-04-20 2020 /pmc/articles/PMC7303098/ /pubmed/32313995 http://dx.doi.org/10.1007/s00204-020-02742-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Toxicogenomics and Omics Technologies
Manier, Sascha K.
Wagmann, Lea
Flockerzi, Veit
Meyer, Markus R.
Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts
title Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts
title_full Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts
title_fullStr Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts
title_full_unstemmed Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts
title_short Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts
title_sort toxicometabolomics of the new psychoactive substances α-pbp and α-pep studied in heparg cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts
topic Toxicogenomics and Omics Technologies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303098/
https://www.ncbi.nlm.nih.gov/pubmed/32313995
http://dx.doi.org/10.1007/s00204-020-02742-1
work_keys_str_mv AT maniersaschak toxicometabolomicsofthenewpsychoactivesubstancesapbpandapepstudiedinhepargcellincubatesbymeansofuntargetedmetabolomicsrevealedunexpectedaminoacidadducts
AT wagmannlea toxicometabolomicsofthenewpsychoactivesubstancesapbpandapepstudiedinhepargcellincubatesbymeansofuntargetedmetabolomicsrevealedunexpectedaminoacidadducts
AT flockerziveit toxicometabolomicsofthenewpsychoactivesubstancesapbpandapepstudiedinhepargcellincubatesbymeansofuntargetedmetabolomicsrevealedunexpectedaminoacidadducts
AT meyermarkusr toxicometabolomicsofthenewpsychoactivesubstancesapbpandapepstudiedinhepargcellincubatesbymeansofuntargetedmetabolomicsrevealedunexpectedaminoacidadducts